Employees: 1,522
Size Galaxy Surfactants (GALAXYSURF.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $845M, the 656th largest of 1,066 India companies the cockpit tracks. Shares closed at ₹2,217 on 18 Nov 2026.
Performance Over six months the shares gained 22.2%, against +4.3% for the median peer and +3.8% for the India market (cap-weighted) — 6th highest of 21 in its peer set.
Growth Revenue grew 30.2% over the last twelve months (peer median +10.2%); the operating margin is 8.7% (peer median 9.9%).
Valuation It trades at 17.6× forward earnings against a peer median of 18.9× (8th cheapest of 20).
Price implies For today's price to make sense, revenue must grow about 19% a year for seven years (Req g). Recent delivered growth is +14%, so the hurdle is +5 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 1.8 points above its cost of capital (14.4% WACC).
Next results Next results expected around 8 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹62.4B | ₹52.3B | ₹42.0B | ₹37.7B | ₹44.3B |
| Revenue growth | — | +24% | +12% | -15% | — |
| Gross profit | ₹11.9B | ₹7.55B | ₹8.03B | ₹7.15B | ₹9.03B |
| EBITDA | ₹6.80B | ₹4.62B | ₹4.70B | ₹4.42B | ₹5.42B |
| Net income | ₹4.07B | ₹2.67B | ₹3.05B | ₹3.01B | ₹3.81B |
| Free cash flow | n/a | ₹1.85B | ₹2.01B | ₹3.51B | ₹4.06B |
| Capital expenditure | n/a | ₹1.37B | ₹2.19B | ₹1.58B | ₹1.46B |
| Total debt | ₹2.95B | ₹2.35B | ₹2.10B | ₹1.87B | ₹3.27B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | GALAXYSURF.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -9.1% | -2.1% | 8th lowest of 21 |
| 6-month return | +22.2% | +4.3% | 6th highest of 21 |
| Distance from 52-week high | -17.8% | -33.6% | 7th highest of 21 |
| Revenue growth (TTM) | +30.2% | +10.2% | 4th highest of 21 |
| Operating margin | 8.7% | 9.9% | 10th lowest of 21 |
| Forward P/E | 17.6× | 18.9× | 8th cheapest of 20 |
| Growth the price implies (Req g, 7 yrs) | 18.5% | 4.3% | 4th most demanding of 18 |
| Growth delivered (Del g) | +13.7% | +8.2% | 6th highest of 18 |
| Hurdle (Req g minus delivered) | +4.8 pp | -4.4 pp | 6th most demanding of 18 |
| ROIC minus cost of capital | +1.8 pp | +7.1 pp | 8th lowest of 21 |
| EV / EBITDA | 10.9× | 9.6× | 4th most expensive of 13 |
| Net debt / EBITDA | -0.7× | -1.1× | 6th most indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Galaxy Surfactants GALAXYSURF.NS | India | $845M | +22% | +30% | 9% | 17.6× | 18.5% | +13.7% |
| Cosmecca Korea 241710.KS | South Korea | $847M | +23% | +42% | 12% | 16.3× | n/a | n/a |
| SYoung 300740.SZ | China | $816M | -48% | +14% | 3% | 33.4× | 14.0% | +6.1% |
| Dencare (Chongqing) Oral Care 001328.SZ | China | $912M | +13% | +10% | 11% | 27.9× | 3.7% | +10.8% |
| Runben Biotechnology 603193.SS | China | $918M | -30% | +13% | 21% | 18.5× | 1.5% | +28.4% |
| Tongling Jieya Biologic Technology 301108.SZ | China | $933M | +56% | +24% | 5% | 52.5× | 28.5% | +0.8% |
| Jyothy Labs JYOTHYLAB.NS | India | $762M | -9% | +5% | 8% | 40.8× | 34.5% | +8.9% |
| Milbon 4919.T | Japan | $743M | +48% | +8% | 14% | 25.7× | -3.3% | +8.2% |
| Noevir 4928.T | Japan | $978M | +7% | -3% | 28% | 20.4× | -12.8% | +4.1% |
| Hangzhou Haoyue Personal Care 605009.SS | China | $726M | -18% | +10% | 6% | 17.7× | 4.4% | +7.7% |
| Shanghai Forest Cabin Cosmetics 2657.HK | Hong Kong | $1.04B | +15% | +74% | 18% | 11.8× | 11.3% | +49.0% |
| d'Alba Global 483650.KS | South Korea | $1.13B | -55% | +49% | 22% | 12.0× | -6.6% | +53.0% |
| Shanghai Chicmax Cosmetics 2145.HK | Hong Kong | $1.17B | -42% | +23% | 8% | 14.4× | -6.1% | +21.2% |
| Bajaj Consumer Care BAJAJCON.NS | India | $560M | -24% | +29% | 22% | 19.7× | 14.8% | +5.0% |
| Edgewell Personal Care EPC | United States | $1.30B | +67% | -10% | 7% | 14.2× | n/a | n/a |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.35B | +27% | 0% | 3% | 37.3× | 28.8% | +22.8% |
| PZ Cussons PZC.L | United Kingdom | $527M | +13% | +5% | 11% | 12.7× | -2.3% | -2.1% |
| Intercos ICOS.MI | Italy | $1.43B | +12% | -5% | 9% | 18.9× | 4.3% | +11.5% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.51B | -39% | +28% | 20% | 21.4× | 7.5% | +3.6% |
| Qingdao Kingking Applied Chemistry 002094.SZ | China | $454M | -26% | +3% | 4% | n/a | n/a | n/a |
| AMOREPACIFIC 002790.KS | South Korea | $1.61B | +2% | +9% | 9% | 8.5× | -5.7% | -1.3% |